Pavlovich Christian P, Grubb Robert L, Hurley Kathleen, Glenn Gladys M, Toro Jorge, Schmidt Laura S, Torres-Cabala Carlos, Merino Maria J, Zbar Berton, Choyke Peter, Walther McClellan M, Linehan W Marston
Urologic Oncology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute and Basic Research Program, SAIC-Frederick, Inc., Frederick, Maryland, USA.
J Urol. 2005 May;173(5):1482-6. doi: 10.1097/01.ju.0000154629.45832.30.
Herein we describe the evaluation and management of renal tumors in Birt-Hogg-Dubé (BHD), an autosomal dominant disorder predisposing to cutaneous fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax and renal tumors.
A total of 124 affected individuals underwent comprehensive clinical evaluation, including body computerized tomography, to determine cutaneous, pulmonary and renal manifestations of BHD. Of these individuals 14 had their renal tumors managed at our institution.
Of the 124 BHD affected individuals 34 (27%) had renal tumors of various histologies, most commonly hybrid oncocytic tumor and chromophobe renal carcinoma. Average age at renal tumor detection was 50.4 years and multiple tumors were found in a majority of patients. Some patients with renal tumors were identified that did not have the characteristic cutaneous hallmarks of BHD. In 4 of the 14 patients treated at our institution small (less than 3 cm) renal tumors were observed, while 10 others underwent a total of 12 renal procedures, including 4 radical and 8 partial nephrectomies. At a median of 38 months of followup 5 of these 10 patients remained free of disease, 3 had small renal tumors and 2 died of metastatic renal cancer.
Patients with BHD are at risk for multiple renal tumors that are often malignant and can metastasize. Individuals at risk or affected by BHD should be radiographically screened for renal tumors at periodic intervals and they are best treated with nephron sparing surgical approaches. Genetic testing for this syndrome is now available.
本文描述了Birt-Hogg-Dubé综合征(BHD)患者肾肿瘤的评估与管理,BHD是一种常染色体显性遗传病,易引发皮肤纤维毛囊瘤、肺囊肿、自发性气胸和肾肿瘤。
总共124例患者接受了全面的临床评估,包括全身计算机断层扫描,以确定BHD的皮肤、肺部和肾脏表现。其中14例患者在我们机构接受了肾肿瘤治疗。
124例BHD患者中,34例(27%)患有不同组织学类型的肾肿瘤,最常见的是混合嗜酸细胞瘤和嫌色性肾细胞癌。肾肿瘤确诊时的平均年龄为50.4岁,大多数患者为多发肿瘤。部分肾肿瘤患者未出现BHD特有的皮肤特征。在我们机构治疗的14例患者中,4例观察到较小(小于3 cm)的肾肿瘤,另外10例共接受了12次肾脏手术,包括4例根治性肾切除术和8例部分肾切除术。随访38个月时,这10例患者中5例无疾病复发,3例有小的肾肿瘤,2例死于转移性肾癌。
BHD患者有发生多个肾肿瘤的风险,这些肿瘤通常为恶性且可转移。有BHD风险或已患病的个体应定期进行肾脏肿瘤的影像学筛查,最佳治疗方法是保留肾单位的手术方式。目前已有针对该综合征的基因检测。